Objective. Functional impairment of coronary microcirculation is thought to be a major pathway in the development of primary cardiac involvement in SSc; however, the underlying mechanism is not fully understood. We aimed to investigate the mechanisms of coronary flow reserve (CFR) reduction in patients with SSc.
Introduction
SSc is characterized by fibrosis and vascular abnormalities of skin and internal organs. Recent epidemiological studies suggest that besides pulmonary involvement cardiovascular disease produces the highest mortality in SSc, as cardiovascular deaths are consistently reported to be responsible for 2030% of all premature deaths [14] . Furthermore, macrovascular arterial changes frequently appear in combination with microvascular disease, representing a diagnostic and prognostic challenge [1, 5] . Myocardial involvement in SSc (SScMI), which is characterized by contractile dysfunction, conduction disturbances and arrhythmias, has been hypothesized to be provoked by ischaemia; however, the underlying mechanism is not fully elucidated [6] . The potential mechanisms include macrovascular and microvascular damage, and arteriolar vasospasm that is analogous to RP may lead to reversible attacks of ischaemia in response to cold provocation [79] .
Alterations of the microvasculature may play a crucial role in the development of SScMI [10] . Observations suggest that coronary flow reserve (CFR) is reduced in SSc.
Kahan et al. [11] first measured invasively the coronary sinus blood flow, and described that some patients had markedly reduced coronary vasodilatory response despite the lack of atherosclerotic coronary artery disease (CAD). Recent studies confirmed this finding among SSc patients; however, mechanisms leading to the restriction of adaptive capacity are still not clear [1118] .
Short-term beneficial effects of vasodilator treatment in terms of better myocardial perfusion and improvement in contractility also supports the concept that reversible ischaemia plays a possible role in SScMI [1922] . The use of calcium channel blockers has recently been found to be protective against left ventricular dysfunction in a large international casecontrol study [23] . Despite the promising data, it is unclear which mechanisms lead to restriction of the CFR, and thus how the pharmacotherapy may target these.
We aimed to investigate the mechanisms of the microvascular impairment by means of analysing the myocardial resistance of SSc patients compared with patients with angina pectoris having mild CAD. Measuring the index of myocardial resistance (IMR) and its changes in response to vasodilator-induced maximal hyperaemia, we found that reduced basal myocardial resistance and acceleration of resting coronary flow explain the reduced coronary adaptation in SSc.
Patients and methods
Diffuse and limited subsets of SSc cases were diagnosed by the commonly used criteria [24] . The study was approved by the Medical Research Council Scientific and Ethical Committee (330/PI/2007) and patients provided informed consent before the study. Each patient underwent a baseline physical examination. Lung involvement was investigated by using chest X-ray, pulmonary function tests and high-resolution CT, if interstitial lung disease was suspected. Duration of RP at the time of the study entry was evaluated by clinical interview, while duration of SSc was determined from the time of onset of the first SSc-related non-Raynaud's symptom. Patients with decreased systolic function (ejection fraction <30% on echocardiography), with known severe valvular disease or with severe lung fibrosis [forced vital capacity (FVC) <50%] were excluded from further investigations. Cardiac catheterization was initiated in the presence of abnormalities that were suggestive of pulmonary arterial hypertension (PAH) or of CAD. Detailed criteria for catheterization are published elsewhere [5] .
Briefly, criteria for the suspected PAH included signs of right ventricular involvement on echocardiography (tricuspid insufficiency diagnosed by flow velocity >3 m/s, or consistent with 2.53 m/s in the presence of unexplained dyspnoea, signs of right ventricular hypertrophy/dilatation or right ventricular D sign) and effort-related dyspnoea with disproportional decrease of carbon monoxide diffusion capacity (DL CO ) compared with the FVC (FVC/DL CO >1.8). Patients were included in the suspected CAD group if they reported recent deterioration in physical activity, evolving effort dyspnoea or chest pain, or fulfilled the criteria of the New York Heart Association functional classes IIIIV, or if their 6-min walking distance was <380 m, but it did not fulfil the criteria for PAH [5, 25] . Coronary angiographic findings and CFR data of the first 10 consecutive patients were included in our previous publication [5] . The subsequent seven SSc patients were enrolled according to the same protocol for investigation of the myocardial resistance levels. Altogether 154 patients were screened using the same protocol resulting in 37 cardiac catheterizations, where the last consecutive cases were included in the current report. Calcium antagonist therapy was stopped for >24 h before cardiac catheterization. Right heart catheterization (RHC) and coronary angiography, supplemented with thermodilution CFR assessment were performed at the same time. Intracoronary pressure wire measurements of 17 patients with intermediate coronary lesions were used as control.
Echocardiography
Echocardiography was performed on every patient using Aloka ProSound 5500 ultrasound equipment. Ejection fraction was measured by Simpson's biplane method. Peak of the early (E) and late (A) velocities of the transmitral Doppler flow were measured from the apical four-chamber view. Systolic pulmonary artery pressure was estimated by using the simplified Bernoulli equation, and calculated from the peak tricuspid regurgitation velocity (4v 2 plus estimated right atrial pressure according to the diameter and collapse index of the inferior vena cava).
RHC
A SwanGanz catheter (B. Braun, Melsungen, Germany) was introduced into a main pulmonary artery branch. If the resting mean pulmonary pressure (mPAP) was <30 mmHg, a 3-min bench-fly physical stress test was performed with 1 kg dumbbells. The mPAP was measured at rest and at peak exercise.
Coronary angiography
Angiograms were recorded digitally (Philips Integris, Eindhoven, The Netherlands) at a speed of 12.5 or 25 frames/s with a 5 Fr catheter using a pressure-operated pump (ACIST HD101, Eden Prairie, MN, USA). Coronary lesions were assessed by visual estimation as well as with quantitative coronary angiography (QCA). The synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) score, a validated comprehensive angiographic scoring system, was used to describe the extent of the CAD [26] . The target artery was instrumented with an intracoronary pressure wire (Radi Medical, Uppsala, Sweden). After baseline measurements of aortic pressure (P a ), distal coronary pressure (P d ) and mean transit time of a room temperature 3-ml saline bolus, measurements were performed in triplicate in the presence of maximal hyperaemia induced by intracoronary papaverine (12 mg bolus). Fractional flow reserve (FFR) was calculated as P d /P a ratio during hyperaemia. CFR was calculated from the ratio of the mean transit times in hyperaemia and at rest. IMR was calculated as a product of mean transit time and P d , in hyperaemia and at rest ( Fig.  1 ). Coronary flow velocity was assessed by the thrombolysis in myocardial infarction (TIMI) frame count (TFC) (i.e. counting the cine frames required for contrast to leave the catheter tip and to reach standardized distal landmarks in the coronaries). TFC was measured offline using a frame counter on a digital DICOM viewer (Inturis Suite ViewerLite v1.0; Philips, Eindhoven, The Netherlands) by a single observer who was blinded to clinical diagnosis.
Statistical analyses
Continuous variables are presented as mean (S.D. 
Results
Demographics, treatment and echocardiographic characteristics of the included patients are depicted in Table 1 , while patient characteristics and pulmonary findings of the SSc patients are summarized in Table 2 . The control group was matched for gender and age. Cardiovascular risk profile was similar except for the more frequent diabetes in the control group. All SSc patients but none of the controls reported the presence of RP. Regarding therapy, the patients in the control group used significantly less calcium channel blockers, pentoxyphylline, CYC and CSs. Baseline haemodynamic data were similar between the two groups. The severity of coronary atherosclerosis as expressed by the QCA and SYNTAX scores did not differ significantly (P = 0.830 and P = 0.821, respectively). The SSc patient group and the control group were similar with regard to TFC, FFR and CFR (P = 0.604, P = 0.651 and P = 0.117, respectively; Table 3 ). The IMR bas was not significantly higher in the SSc group (P = 0.207), and in (Fig. 2C ). There was no significant difference between lcSSc and dcSSc of SSc as regards CFR, IMR bas and IMR hyp results. Clinical complaints showed no relation to these parameters (data not shown). (Fig. 2D ).
Discussion
To our knowledge, this is the first study that assessed the myocardial resistance in SSc patients by intracoronary pressure wire measurement. The main finding of our investigation is that the IMR in hyperaemia (IMR hyp ) is not increased in SSc patients compared with controls having no significant epicardial coronary artery stenosis. It suggests that there is no irreversible damage at the level of the coronary arterioles in SSc. Coronary arterioles are responsible for the distribution of the myocardial blood flow. Their function is subject to delicate regulation by different signals of local ischaemia. It has been hypothesized on the basis of recent studies that in SSc patients the loss of the arterioles and consequent reduction of the arteriolar bed's cross-section result in an increased hyperaemic resistance [6, 15] . This concept, however, was not confirmed by our results. At the same time, in SSc patients with reduced CFR, we demonstrated a decrease in the resting myocardial resistance (IMR bas) together with accelerated flow velocity. This suggests the presence of a compensatory mechanism to maintain myocardial perfusion at rest already. This process may cause exhaustion of the adaptive capacity and results in ischaemia at a lower threshold. The presence of myocardial ischaemia among SSc patients is supported by multiple studies investigating myocardial perfusion in SSc demonstrating irreversible as well as reversible perfusion defects. Myocardial perfusion improved after administration of vasodilatory agents suggesting the lack of irreversible arteriolar damage [13, 16, 27, 28] . This finding is in concordance with our results.
The capillary field is exceptionally dense in the heart, providing one capillary to one myocyte [29] . Loss of capillaries thus would not reduce the hyperaemic resistance, yet may lead to ischaemia of the contractile elements. We found that SSc patients with reduced CFR exhibited decreased basal resistance. In the presence of coronary stenosis, the reduction in basal tone at rest is a compensatory mechanism that tends to maintain the myocardial perfusion despite decreased distal coronary perfusion pressure [30, 31] . In our current cohort, not a single patient had haemodynamically significant coronary stenosis and consequently compensation for diminished distal coronary pressure can be excluded. It means that decrease in resting resistance with accelerated flow may be a consequence of compensatory mechanisms alerted by ischaemic signals from the myocardium.
Former studies could only estimate coronary flow parameters in SSc patients. Nitenberg et al. [15] have investigated the coronary blood flow and myocardial resistance levels invasively; the coronary perfusion pressure was calculated and coronary blood flow was evaluated using thermodilution measurements in the coronary sinus. Without direct measurement of P d , a diffuse but haemodynamically significant stenosis cannot be excluded. Our data are based on direct invasive measurements of intracoronary pressures, which provide HAQ-DI: HAQ disability index [40] ; DL CO /VA: carbon monoxide diffusing capacity adjusted for alveolar volume.
more accurate pressure values enhancing the strength of our findings. Several studies have attempted to characterize non-invasively coronary vasoreactivity in SSc patients [12, 13, 16] . Measurement of the diastolic coronary flow obtained by trans-thoracic echocardiography initially has been reported to exhibit suboptimal feasibility, which can be improved by using contrast augmentation of the Doppler signal and second harmonic technology (CFR echo ) [14, 32, 33] . Sulli et al. [16] found significantly lower CFR echo values among patients with diffuse SSc than in subjects suffering from the limited form of the disease. In our cohort, such a difference has not been found.
Montisci et al. [14] found that peak diastolic velocity was significantly decreased in the left anterior descending coronary artery in basal conditions and CFR echo measured during adenosine infusion increased significantly after single i.v. L-propionylcarnitine application. It may be interpreted as the anti-endothelin effect of L-propionylcarnitine for microvascular tone and this agent could cause improved sensitivity to adenosine infusion. D'Andrea et al. [12] conclude that endothelial dysfunction in SSc patients was not just confined to coronary microvessels, but also extends to peripheral arteries. Similar results were found earlier by Andersen et al. [34] . A limitation of these studies is the lack of strict pressure measurement allowing only indirect determination of the coronary flow. Further limitation is the lack of information about the coronary anatomy. Coronary heart disease in the forms of coronary artery sclerosis and microvascular disease can be found frequently in combination, in symptomatic SSc patients [5] . Furthermore, clinical presentation of atherosclerosis is atypical in this patient group and coronary abnormalities may be found among symptom-free patients [17, 35] .
Altogether, these culminating data support that abnormal myocardial perfusion causing focal ischaemia is associated with myocardial fibrosis-related structural myocardial disease [6] . Cardiac magnetic resonance studies demonstrated that the presence of areas with late enhancement, corresponding to the fibrotic areas earlier found by autopsy studies, is a common finding [4, 18, 36, 37] . Distribution of the fibrosis did not show a direct relationship to the coronary anatomy; however, CAD is a frequent finding in SSc patients presenting with cardiac symptoms [5] . In a recent study, fibrosis was found in 66% of the SSc cases. These lesions were found more frequently in cases with a long history of RP. There was no different incidence found between diffuse and limited cutaneous forms of SSc [18] . Allanore et al. [19] demonstrated that the myocardial perfusion index can improve after administration of the endothelin receptor antagonist bosentan. This finding confirms our hypothesis that the improvement of endothelial function, which is mainly represented by the capillary system, can repair the myocardial perfusion. In our study, we did not find any correlation with the history of RP; the basal resistance (IMR bas ) of SSc patients did not differ significantly from the controls. The concept that Raynaud's-like mechanisms may be involved in the evolution of the scleroderma-specific internal organ damage is a tempting hypothesis. Mukerjee et al. investigated the effect of central and peripheral cold challenges in 21 SSc patients with PAH [38] . They did not verify significant changes in haemodynamic parameters and in the level of vasoactive peptides after a 2-min long hand immersion into cold water or after administration of 4 C water into the right atrium, so they excluded that cold provocation could alter the pulmonary circulation [38] . Theoretically, haemodynamic changes caused by low temperature in the heart are even less probable. Our results strengthen this statement since the injection of room temperature saline into the coronaries did not provoke angina or spasm and we did not find any increase of the transit times. The IMR bas was not elevated in SSc patients despite the stress situation, and the cool temperature of the cathlab.
Our study has certain limitations. The gender distribution was different in the two groups although this difference was not statistically significant, probably due to the small sample size. Considering the cardiovascular risk factors, the incidence of hypercholesterolaemia was significantly higher in the control group; both of them may influence the vasoreactivity of the coronary arteries. We did not find significant difference in the IMR bas between the SSc groups with CFR 4 2 and CFR > 2. One possible explanation can be the high S.D. of those values. Furthermore, in our current study, we assessed neither the myocardial metabolism nor the myocardial perfusion.
In conclusion, reduced CFR can be considered as a sign of SScMI. Our observations support that in SSc the reduction in the CFR is mainly attributable to a decrease in the basal myocardial resistance, i.e. with lower arteriolar tone and with an accelerated coronary flow velocity. These findings suggest a sort of compensatory state. Vasodilatory treatment may cause further decrease in the tone of the arterioles, which may be primarily effective among patients with retained CFR. Further studies are   FIG. 2 Results of the intracoronary pressure wire measurements. (A) In SSc patients, the myocardial resistance at maximal vasodilatation (IMR hyp ) was not significantly different from that in controls (P = 0.99). The difference in the magnitude of the response to vasodilatation (i.e. the CFR) is dominated by the differences in the resting resistance (IMR bas ), i.e. in the vascular tone. (B) TFCs of SSc patients with normal CFR were significantly higher than in SSc patients with decreased CFR, which indicate accelerated coronary flow among patients with restricted coronary reserve. (C) Baseline myocardial resistance shows significant linear correlation with the coronary flow velocity-assessed by the TFC (Pearson r = 0.56, P < 0.02). (D) Mean transit time values in baseline and in hyperaemia. After injection of room temperature saline, we observed longer transit times among SSc patients; however, this difference was not significant. In response to repeated injections, lack of deceleration of the coronary artery flow suggests the absence of coronary RP.
needed to characterize the mode of action of these vasodilatory drugs in SSc.
Rheumatology key messages
. Myocardial resistance values do not suggest functional damage at the level of coronary arterioles. . Reduced CFR is a compensatory mechanism probably provoked by ischaemic myocardial microcirculation.
